- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Drusen.
Displaying page 1 of 1.
| EudraCT Number: 2005-001598-93 | Sponsor Protocol Number: C-02-60 | Start Date*: 2005-07-05 |
| Sponsor Name:Alcon Research Limited | ||
| Full Title: An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study ... | ||
| Medical condition: non-exudative age related macular degeneration (dry AMD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DK (Completed) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001385-16 | Sponsor Protocol Number: 7 | Start Date*: 2008-02-21 |
| Sponsor Name:Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Rudolf Foundation Clinic | ||
| Full Title: Rheohemapheresis and Lutein Supplementation (xantophyll carotenoid) in the Non-Exsudative Form of Age-Related Macular Degeneration. (ReLux-AMD) | ||
| Medical condition: Non-exsudative age-related macular degeneration | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005686-11 | Sponsor Protocol Number: SP878 | Start Date*: 2006-02-21 |
| Sponsor Name:SCHWARZ PHARMA Deutschland GmbH | ||
| Full Title: CONFIRMATORY, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUPS STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROSTAGLANDIN E1 IN SUBJECTS WITH DRY AGE-RELATED MACULAR DEGENER... | ||
| Medical condition: Patients with dry age-related macular degeneration | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005556-25 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.2 | Start Date*: 2015-05-11 |
| Sponsor Name:Investigacion Independiente | ||
| Full Title: Open extension study for patients with age related macula degeneration who participated in the Fase IV-II clinical trial randomized, simulatedcontrolled treatment to evaluate safety and efficacy o... | ||
| Medical condition: Aged related macula degeneration (ARMD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001812-36 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.3 | Start Date*: 2015-08-11 |
| Sponsor Name:Dr. Pedro Cuevas Sanchez (Investigacion Independiente) | ||
| Full Title: Extension study for the follow up of patients with age related macula degeneration who participated in the Fase IV-II clinical trial randomized, simulated controlled treatment to evaluate safety an... | ||
| Medical condition: Aged related macula degeneration (ARMD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-002381-73 | Sponsor Protocol Number: PATP1023 | Start Date*: 2014-10-02 |
| Sponsor Name:Moorfields Eye Hospital | ||
| Full Title: Individualizing therapy for neovascular age-related macular degeneration with aflibercept | ||
| Medical condition: Neovascular age-related macular degeneration | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000946-24 | Sponsor Protocol Number: 15-EI-0202 | Start Date*: 2018-01-09 |
| Sponsor Name:National Eye Institute | ||
| Full Title: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration | ||
| Medical condition: Geographic Atrophy Associated with Age-Related Macular Degeneration | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003899-31 | Sponsor Protocol Number: DBC-AMD-001-D | Start Date*: 2018-05-28 | |||||||||||
| Sponsor Name:DOBECURE, S.L | |||||||||||||
| Full Title: International, multicenter, randomised, blind, sham-controlled, 2x2 cross over phase III clinical trial to assess the efficacy and security of an intravitreal injection of Etamsylate in the improv... | |||||||||||||
| Medical condition: Aged related macula degeneration (AMD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) PT (Ongoing) IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-003204-12 | Sponsor Protocol Number: ICI21/00025 | Start Date*: 2022-03-16 | |||||||||||
| Sponsor Name:Consorcio PSMAR | |||||||||||||
| Full Title: Multicentre, randomised, double-blind, parallel-group, Phase III study to evaluate the genetic polymorphisms influence in the response to Ranibizumab and Bevacizumab treatment in patients with Age-... | |||||||||||||
| Medical condition: age-related macular degeneration | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-003320-36 | Sponsor Protocol Number: 190342-038 | Start Date*: 2015-03-02 | |||||||||||
| Sponsor Name:Allergan Limited | |||||||||||||
| Full Title: Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study) | |||||||||||||
| Medical condition: Geographic Atrophy Secondary to Age-related Macular Degeneration | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-005259-20 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.1 | Start Date*: 2015-02-13 | |||||||||||
| Sponsor Name:Investigacion Independiente | |||||||||||||
| Full Title: FASE IV-II CLINICAL TRIAL, PROOF OF CONCEPT, RANDOMIZED, SIMULATED CONTROLLED TREATMENT, DOUBLE BLINDED AND UNICENTRIC WITH TWO PARALLEL GROUPS, TO EVALUATE SAFETY AND EFFICACY OF INTRAVITREAL ADMI... | |||||||||||||
| Medical condition: Aged related macula degeneration (ARMD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-001198-22 | Sponsor Protocol Number: ALXN2040-GA-201 | Start Date*: 2021-12-02 | |||||||||||
| Sponsor Name:Alexion Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | |||||||||||||
| Medical condition: Geographic Atrophy (AD) secondary to Age-related Macular Degeneration (AMD). | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LV (Ongoing) CZ (Ongoing) SK (Ongoing) ES (Ongoing) IT (Ongoing) HU (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-002531-15 | Sponsor Protocol Number: 09/0959 | Start Date*: 2016-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:UCL Comprehensive Clinical Trials Unit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A phase II, open label, non-randomised, single centre, clinical trial of ANX776 in Healthy Volunteers and patients with Glaucoma, Age-Related Macular Degeneration, and Optic Neuritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Glaucoma, Age-related Macular Degeneration, and Optic Neuritis. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
